financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,451,442, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,451,442, According to a Recent SEC Filing
Jul 5, 2024 6:07 AM

08:50 AM EDT, 07/05/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on July 03, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,451,442. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 484,828 shares of the company, with 484,828 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218024005623/xslF345X03/primarydocument.xml

Price: 181.00, Change: -1.26, Percent Change: -0.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
Jun 26, 2024
09:35 AM EDT, 06/26/2024 (MT Newswires) -- Oramed Pharmaceuticals ( ORMP ) said Wednesday that its board approved a share-buyback program of up to $20 million. The program is effective over a 12-month period and will be funded with existing cash, the company said. Price: 2.41, Change: +0.17, Percent Change: +7.59 ...
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday?
Jun 26, 2024
The latest trial study from Savara Inc ( SVRA ) met its primary endpoint. The company released results from Phase 3 IMPALA-2 trial of molgramostim 300 mcg administered once daily by inhalation with a matching placebo for autoimmune pulmonary alveolar proteinosis (aPAP). Matt Pauls, CEO Savara, praised the results. PAP is a rare lung disease caused by a buildup of proteins,...
General Mills Fiscal Fourth-Quarter Sales Fall On Volume, Price Headwinds
General Mills Fiscal Fourth-Quarter Sales Fall On Volume, Price Headwinds
Jun 26, 2024
09:33 AM EDT, 06/26/2024 (MT Newswires) -- General Mills' ( GIS ) sales fell in the fiscal fourth quarter amid lower volume and pricing headwinds as the Cheerios maker provided a weak full-year earnings outlook. The packaged foods maker's adjusted earnings came in at $1.01 a share for the quarter ended May 26, down from $1.12 the year before, but...
Phillips 66 Boosts Renewable Fuel Production Rates
Phillips 66 Boosts Renewable Fuel Production Rates
Jun 26, 2024
09:33 AM EDT, 06/26/2024 (MT Newswires) -- Phillips 66 (PSX) said Wednesday that it has completed the conversion of its Rodeo facility in the San Francisco Bay Area to expand its renewable fuel output. The company said the Rodeo facility has increased rates to 50,000 barrels per day, or 800 million gallons a year, reaching the company's goal of reaching...
Copyright 2023-2026 - www.financetom.com All Rights Reserved